Status:
NOT_YET_RECRUITING
A Detailed Look At What Patients Experience In Medullary Thyroid Cancer Clinical Study
Lead Sponsor:
Power Life Sciences Inc.
Conditions:
Medullary Thyroid Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Clinical studies, with a distinct emphasis on medullary thyroid cancer, play a pivotal role in evaluating the safety and effectiveness of novel treatments for this condition. These trials serve as ess...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of medullary thyroid cancer
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
- No serious medical or psychiatric illness likely to interfere with participation in this clinical study.
Exclusion
- Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study
- Any serious and/or unstable pre-existing medical disorders
- Patients who are currently receiving any other investigational drug.
Key Trial Info
Start Date :
November 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06079723
Start Date
November 1 2024
End Date
November 1 2026
Last Update
October 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Power Life Sciences
San Francisco, California, United States, 94107